Applied Therapeutics
(NASDAQ) APLT
Applied Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.00M
Net Income (TTM)
$18.14M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
APLT News
APLT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Applied Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
35
CEO
Les Funtleyder
Website
www.appliedtherapeutics.comHeadquarters
New York City, NY 10017, US
APLT Financials
Key Financial Metrics (TTM)
Gross Margin
-28%
Operating Margin
-98%
Net Income Margin
-18%
Return on Equity
-66%
Return on Capital
-67%
Return on Assets
-53%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$48.29M
Operating Income
$104.30M
EBITDA
$104.30M
Operating Cash Flow
$84.31M
Capital Expenditure
$0.00
Free Cash Flow
$84.31M
Cash & ST Invst.
$79.40M
Total Debt
$2.79M
Applied Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.00M
+719.7%
Gross Profit
$1.00M
+719.7%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
35
N/A
Net Income
$18.99M
+72.3%
EBITDA
$18.88M
+36.3%
Quarterly Fundamentals
Net Cash
$9.45M
-90.3%
Accounts Receivable
$16.65M
+6256.1%
Inventory
$0.00
N/A
Long Term Debt
$2.03M
+19.1%
Short Term Debt
$467.00K
+76.9%
Return on Assets
-52.77%
N/A
Return on Invested Capital
-66.85%
N/A
Free Cash Flow
$18.40M
+21.1%
Operating Cash Flow
$18.40M
+21.1%